Dr. Bonomi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
460 W 10th Ave
Columbus, OH 43210Phone+1 614-293-0463Fax+1 614-293-3193
Education & Training
- Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2010 - 2013
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Hospice and Palliative Medicine, 2009 - 2010
- Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2006 - 2009
- University of Buenos AiresClass of 1991
Certifications & Licensure
- OH State Medical License 2017 - 2025
- NC State Medical License 2013 - 2018
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014-2020
- Dr Federico Vierheller Scientific Award to the Scientific Work 2000
- Fist Award in Clinical Trials Section Angel H. Roffo Insitute. XX Multidisciplinary Symposium in Oncology
Clinical Trials
- Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects Start of enrollment: 2011 Jul 01
- Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2013 Oct 14
- A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & Neck Start of enrollment: 2013 Aug 01
Publications & Presentations
PubMed
- Comparative analysis of the tumor microbiome, molecular profiles, and immune cell abundances by HPV status in mucosal head and neck cancers and their impact on survival.Rituraj Upadhyay, Aastha Dhakal, Caroline Wheeler, Rebecca Hoyd, Malvenderjit Jagjit Singh
Cancer Biology & Therapy. 2024-12-31 - Impact of circulating tumor human papillomavirus DNA kinetics on disease outcomes in HPV-associated oropharyngeal cancer.Sachin R Jhawar, Catherine Haring, Xueliang Pan, Jianing Ma, Priyanka Bhateja
International Journal of Cancer. 2024-12-16 - Phase Ib Study of the Immunocytokine Simlukafusp Alfa (FAP-IL2v) in Combination with Cetuximab in Patients with Head and Neck Squamous Cell Carcinoma.Aaron R Hansen, Carlos A Gomez-Roca, Debbie G J Robbrecht, Loic Verlingue, Antoine Italiano
Clinical Cancer Research. 2024-12-16
Journal Articles
- Dusquetide: Reduction in oral mucositis associated with enduring ancillary benefits in tumor resolution and decreased mortality in head and neck cancer patientsKudrimoti M, Curtis A, Azawi S, Worden F, Katz S, Adkins D, Bonomi M, Scott Z, Elder J, Sonis S, Straube R, Donini O, Biotechnol Rep (Amst), 1/17/2017
- The Effects of smoking status and smoking history on patients with brain metastases from lung cancerShenker R, McTyre E, Ruiz J, Weaver K, Cramer C, Alphonse-Sullivan N, Farris M, Petty W, Bonomi M, Watabe K, Laxton A, Tatter S, Warren G, Chan M, Cancer Med, 1/1/2017
- Human papillomavirus-related small cell carcinoma of the oropharynx: a case report and literature reviewBonomi M, Ahmed T, Warner D, Waltonen J, Sullivan C, Porosnicu M, Batt K, Ruiz J, Cappellari J, Cancers of the Head & Neck, 1/1/2017
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Immune response in patients with recurrent or metastatic non-small cell lung cancer and performance status of 2 treated with a combination of pembrolizumab and low do...Addo S, Kooshki M, Petty W, Ruiz J, Ahmed T, Grant S, Triozzi P, Bonomi M, Annual Internal Medicine Research Day, Wake Forest School of Medicine, Winston-Salem, NC, 1/3/2017
- Immune-related saliva micro-RNA’s to predict clinical response to a combination of cetuximab and low-dose chemotherapy in head and neck cancer (HNSCC) patients (pts) w...Bonomi M, Ado S, Kooshki M, Ahmed T, Sullivan C, Waltonen J, Triozzi P, J Clin Oncol, 1/1/2017
- Phase 2 trial of chemotherapy followed by consolidative radiation therapy for initial treatment of oligometastatic NSCLCAhmed T, Urbanic J, Hughes R, D'Agostino R, Lally B, Ruiz D, Chan D, Gandhi P, Dothard A, Rusthoven K, Bonomi M, Blackstock W, Petty W, J Clin Oncol, 1/1/2017
- Join now to see all
Lectures
- Management of Recurrent/Metastatic Head and Neck CancerWinston-Salem, NC - 1/22/2016
- Management of chemo-radiation induced mucositis in head and neck cancer patientsMount Sinai School of Medicine - 1/22/2012
- Management of metastatic head and neck cancerMount Sinai School of Medicine - 1/6/2012
- Join now to see all
Press Mentions
- Columbus Monthly’s Top Doctors in Columbus and Central Ohio for 2020August 18th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: